ABC | Volume 115, Nº1, July 2020

Original Article Derakhshanian et al. Quercetin improves glucocorticoid-induced dyslipidemia Arq Bras Cardiol. 2020; 115(1):102-108 7. D’Andrea G. Quercetin: a flavonol with multifaceted therapeutic applications? Fitoterapia. 2015 Oct;106:256-71. 8. Li Y, Yao J, Han C, Yang J, Chaudhry MT, Wang S, et al. Quercetin, inflammation and immunity. Nutrients. 2016;8(3):167. 9. David AVA, Arulmoli R, Parasuraman S. Overviews of biological importance of quercetin: a bioactive flavonoid. Pharmacogn Rev. 2016;10(20):84-9. 10. Ginwala R, Bhavsar R, ChigbuDI, Jain P, Khan ZK. Potential role of flavonoids in treating chronic inflammatory diseases with a special focus on the anti- inflammatory activity of apigenin. Antioxidants. 2019;8(2):pii:E35. 11. Derakhshanian H, Djalali M, Djazayery A, Javanbakht MH, Zarei M, Hekmatdoost A, et al. Quercetina Melhora o Perfil Lipídico e Apolipoproteico em Ratos Tratados com Glicocorticóides em Altas Doses. Arq Bras Cardiol. 2020; 115(1):102-108. 12. Santhakumar AB, Battino M, Alvarez-Suarez JM. Dietary polyphenols: structures, bioavailability and protective effects against atherosclerosis. Food Chem Toxicol. 2018 Mar;113:49-65. 13. Sahebkar A. Effects of quercetin supplementation on lipid profile: a systematic review and meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr. 2017;57(4):666-76. 14. National ResearchCouncil. Guide for the care and use of laboratory animals. 8th ed. Washington (DC): National Academies Press; 2011. 15. Hazra A, Pyszczynski NA, DuBois DC, Almon RR, Jusko WJ. Modeling of corticosteroid effects on hepatic low-density lipoprotein receptors and plasma lipid dynamics in rats. Pharm Res. 2008;25(4):769-80. 16. Green C, Knight J, Precious S, Simpkin S. Ketamine alone and combined with diazepamor xylazine in laboratory animals: a 10 year experience. Lab Anim. 1981;15(2):163-70. 17. FriedewaldWT, Levy RI, FredricksonDS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499-502. 18. de Vrie JH, Janssen PL, Hollman PC, van Staveren WA, Katan MB. Consumption of quercetin and kaempferol in free-living subjects eating a variety of diets. Cancer Lett. 1997;114(1-2):141-4. 19. Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. 2016;7(2):27-31. 20. Sholter DE, Armstrong PW. Adverse effects of corticosteroids on the cardiovascular system. Can J Cardiol. 2000;16(4):505-11. 21. Van DeWier B, Koek GH, Bast A, Haenen GR. The potential of flavonoids in the treatment of non-alcoholic fatty liver disease. Crit Rev Food Sci Nutr. 2017;57(4):834-55. 22. Seiva FR, Chuffa LG, Braga CP, Amorim JP, Fernandes AA. Quercetin ameliorates glucose and lipid metabolism and improves antioxidant status in postnatallymonosodiumglutamate-inducedmetabolic alterations. Food Chem Toxicol. 2012;50(10):3556-61. 23. Peluso MR. Flavonoids attenuate cardiovascular disease, inhibit phosphodiesterase, and modulate lipid homeostasis in adipose tissue and liver. Exp Biol Med. 2006;231(8):1287-99. 24. Rivera L, Morón R, Sánchez M, Zarzuelo A, Galisteo M. Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats. Obesity. 2008;16(9):2081-7. 25. Mbikay M, Mayne J, Sirois F, Fedoryak O, Raymond A, Noad J, et al. Mice fed a high-cholesterol diet supplemented with quercetin-3-glucoside show attenuated hyperlipidemia and hyperinsulinemia associated with differential regulation of PCSK9 and LDLR in their liver and pancreas. Mol Nutr Food Res. 2018;62(9):1700729. 26. Ishisaka A, Ichikawa S, Sakakibara H, Piskula MK, Nakamura T, Kato Y, et al. Accumulation of orally administered quercetin in brain tissue and its antioxidative effects in rats. Free Radic Biol Med. 2011;51(7):1329-36. 27. Sathe CA, Chogle SA, Bharadwaj D. Apo B/Apo A1 ratio: a risk marker in patients with cardiovascular disease. Int J Res Med. 2017;6(2):20-3. 28. Panayiotou A, Griffin M, Georgiou N, Bond D, Tyllis T, Tziakouri-Shiakalli C, et al. ApoB/ApoA1 ratio and subclinical atherosclerosis. Int Angiol. 2008;27(1):74-80. 29. Simpson CW, Dicara LV,Wolf G. Glucocorticoid anorexia in rats. Pharmacol Biochem Behav. 1974;2(1):19-25. 30. Löfberg E, Gutierrez A, Wernerman J, Anderstam B, Mitch WE, Price SR, et al. Effects of high doses of glucocorticoids on free amino acids, ribosomes and protein turnover in human muscle. Eur J Clin Invest. 2002;32(5):345-53. 31. Sangeetha KSS, Reddy CUM, Kalkura SN. Flavonoids: therapeutic potential of natural pharmacological agents. Int J Pharm Sci Res. 2016;7(10):3924-30. 32. Dugani AM, Alkhetally WI, Elghedafi EO, Alkayed FW. Effects of the aqueous extract fromAbelmoschus esculentus L peel on hyperglycemia and hyperlipidemia induced by dexamethasone in rats. Libyan Int. Med. Univ. J. 2018;3(1):3-7. 33. Derakhshanian H, Djalali M, Djazayery A, Nourijelyani K, Ghadbeigi S, Pishva H, et al. Quercetin prevents experimental glucocorticoid-induced osteoporosis: a comparative study with alendronate. Can J Physiol Pharmacol. 2013;91(5):380-5. 107